These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 6190882
61. Assessment of serology and spirometry and the combination of both to complement microbiological isolation for earlier detection of Pseudomonas aeruginosa infection in children with cystic fibrosis. Kotnik Pirš A, Krivec U, Simčič S, Seme K. BMC Pulm Med; 2016 Nov 25; 16(1):161. PubMed ID: 27884144 [Abstract] [Full Text] [Related]
62. [Pseudomonas aeruginosa infection in cystic fibrosis: predominance of a single strain and the influence of antibiotic therapy and the environment]. Michel-Briand Y, Plesiat P, Godard C, Noir A, Estavoyer JM. Bull Acad Natl Med; 1992 Nov 25; 176(8):1159-69; discussion 1170-1. PubMed ID: 1300222 [Abstract] [Full Text] [Related]
63. An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. Clifton IJ, Fletcher LA, Beggs CB, Denton M, Conway SP, Peckham DG. J Cyst Fibros; 2010 Jan 25; 9(1):64-8. PubMed ID: 19944655 [Abstract] [Full Text] [Related]
64. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Whiteford ML, Wilkinson JD, McColl JH, Conlon FM, Michie JR, Evans TJ, Paton JY. Thorax; 1995 Nov 25; 50(11):1194-8. PubMed ID: 8553277 [Abstract] [Full Text] [Related]
65. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study. López-Causapé C, de Dios-Caballero J, Cobo M, Escribano A, Asensio Ó, Oliver A, Del Campo R, Cantón R, Solé A, Cortell I, Asensio O, García G, Martínez MT, Cols M, Salcedo A, Vázquez C, Baranda F, Girón R, Quintana E, Delgado I, de Miguel MÁ, García M, Oliva C, Prados MC, Barrio MI, Pastor MD, Olveira C, de Gracia J, Álvarez A, Escribano A, Castillo S, Figuerola J, Togores B, Oliver A, López C, de Dios Caballero J, Tato M, Máiz L, Suárez L, Cantón R. Int J Antimicrob Agents; 2017 Sep 25; 50(3):334-341. PubMed ID: 28735882 [Abstract] [Full Text] [Related]
66. Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients. Hall AJ, Fothergill JL, McNamara PS, Southern KW, Winstanley C. Diagn Microbiol Infect Dis; 2014 Dec 25; 80(4):324-6. PubMed ID: 25284374 [Abstract] [Full Text] [Related]
67. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Griffiths AL, Jamsen K, Carlin JB, Grimwood K, Carzino R, Robinson PJ, Massie J, Armstrong DS. Am J Respir Crit Care Med; 2005 May 01; 171(9):1020-5. PubMed ID: 15709051 [Abstract] [Full Text] [Related]
68. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Pedersen SS, Høiby N, Espersen F, Koch C. Thorax; 1992 Jan 01; 47(1):6-13. PubMed ID: 1539148 [Abstract] [Full Text] [Related]
69. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Li Y, Zhang X, Wang C, Hu Y, Niu X, Pei D, He Z, Bi Y. Mol Med Rep; 2015 Jan 01; 11(1):494-8. PubMed ID: 25323940 [Abstract] [Full Text] [Related]
70. Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis. Boukadida J, De Montalembert M, Lenoir G, Scheinmann P, Véron M, Berche P. J Med Microbiol; 1993 Jan 01; 38(1):29-33. PubMed ID: 8418289 [Abstract] [Full Text] [Related]
71. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy. Cigana C, Melotti P, Baldan R, Pedretti E, Pintani E, Iansa P, De Fino I, Favari F, Bergamini G, Tridello G, Cirillo DM, Assael BM, Bragonzi A. BMC Microbiol; 2016 Jul 11; 16(1):142. PubMed ID: 27400750 [Abstract] [Full Text] [Related]
72. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK. Thorax; 2003 Jun 11; 58(6):525-7. PubMed ID: 12775867 [Abstract] [Full Text] [Related]
73. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Viel M, Hubert D, Burgel PR, Génin E, Honoré I, Martinez B, Gaitch N, Chapron J, Kanaan R, Dusser D, Girodon E, Bienvenu T. Clin Respir J; 2016 Nov 11; 10(6):777-783. PubMed ID: 25763772 [Abstract] [Full Text] [Related]
74. Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp--a molecular-epidemiological study. Hunfeld KP, Schmidt C, Krackhardt B, Posselt HG, Bargon J, Yahaf Y, Schäfer V, Brade V, Wichelhaus TA. Wien Klin Wochenschr; 2000 Apr 07; 112(7):329-33. PubMed ID: 10849957 [Abstract] [Full Text] [Related]
75. Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis. Taylor RF, Morgan DW, Nicholson PS, Mackay IS, Hodson ME, Pitt TL. Thorax; 1992 Jun 07; 47(6):426-8. PubMed ID: 1496501 [Abstract] [Full Text] [Related]
76. Pseudomonas aeruginosa colonisation in an intensive therapy unit: role of cross infection and host factors. Noone MR, Pitt TL, Bedder M, Hewlett AM, Rogers KB. Br Med J (Clin Res Ed); 1983 Jan 29; 286(6362):341-4. PubMed ID: 6402090 [Abstract] [Full Text] [Related]
77. Dental units as infection sources of Pseudomonas aeruginosa. Barben J, Schmid J. Eur Respir J; 2008 Oct 29; 32(4):1122-3. PubMed ID: 18827162 [No Abstract] [Full Text] [Related]
78. Pseudomonas cepacia in cystic fibrosis patients. Prince A. Am Rev Respir Dis; 1986 Oct 29; 134(4):644-5. PubMed ID: 3094414 [No Abstract] [Full Text] [Related]